Clinical Trial Update: Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan

View source ↗

Summary

A completed Taiwan trial comparing tiotropium plus olodaterol to inhaled corticosteroids plus a long-acting beta-agonist in COPD patients, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ICS+LABA (inhaled corticosteroid + long-acting beta-agonist)
• Stiolto Respimat (tiotropium + olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2024-08-09